Validation of distant metastases risk-groups in oral cavity squamous cell carcinoma patients treated with postoperative intensity-modulated radiotherapy.

BACKGROUND This study aimed to derive distant metastases (DM) risk-groups in oral cavity squamous cell carcinoma (OSCC) patients treated with postoperative intensity-modulated radiation therapy (PO-IMRT). METHODS OSCC patients treated with PO-IMRT were divided into discovery (2005-2012) and validation (2013-2014) cohorts. DM predictors were identified from multivariable analysis (MVA) to derive low- and high-risk groups in the discovery-cohort. The result was subsequently evaluated in validation-cohort. RESULTS Overall 447 patients were included (discovery-cohort: n = 300, and validation-cohort: n = 147). Between the two cohorts, there were no significant differences in DM (p = 0.16) or OS (p = 0.26). MVA identified pN2-3 and histological grade 2-3 (G2-3) as DM predictors. High-risk group included patients who had both poor predictors (pN2-3 and G2-3), while low-risk group included patients with no or only one poor predictor. In discovery-cohort, 3-year distant control (DC) was 78% and 97% in high- and low-risk groups respectively (p < 0.001, concordance index = 0.72). In validation-cohort, risk-group classification performed similarly (concordance index = 0.73). The 3-year OS for high- versus low-risk group was 85% versus 95% in discovery-cohort (p < 0.001), and 74% versus 93% in validation-cohort (p < 0.001). CONCLUSION A model (G2-3/pN2-3) which identifies high DM risk was validated internally. This model might be used to design future prospective studies investigating treatment intensification and/or DM surveillance.

• Publication year

  2019

• Venue

  Radiotherapy and Oncology

• Publication date

  2019-01-31

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1016/J.RADONC.2019.01.014PMID 31005202
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Distant Metastases Following Postoperative Intensity-Modulated Radiotherapy for Oral Cavity Squamous Cell Carcinoma

  2017cited by this paper
• Lymph node ratio relationship to regional failure and distant metastases in oral cavity cancer.

  2017cited by this paper
• Risk factors of distant metastasis in patients with squamous cell carcinoma of the oral cavity.

  2016cited by this paper
• Squamous cell carcinoma of the oral cavity often overexpresses p16 but is rarely driven by human papillomavirus.

  2016cited by this paper
• Global cancer statistics, 2012

  2015cited by this paper
• Resection of subsequent pulmonary metastases from treated head and neck squamous cell carcinoma: systematic review and meta‐analysis

  2015cited by this paper
• Screening for distant metastases in head and neck cancer patients using FDG-PET and chest CT: validation of an algorithm

  2015cited by this paper
• Risk Factors Associated with Distant Metastasis in Patients with Oral Squamous Cell Carcinoma

  2015cited by this paper
• Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234.

  2014cited by this paper
• Local ablative treatments of oligometastases from head and neck carcinomas.

  2014cited by this paper
• Preoperative chemotherapy in advanced resectable OCSCC: long-term results of a randomized phase III trial.

  2014cited by this paper
• Improvement in survival of patients with oral cavity squamous cell carcinoma: An international collaborative study

  2013cited by this paper
• Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma.

  2013cited by this paper
• Risk factors for distant metastasis in squamous cell carcinoma of the oral cavity.

  2013cited by this paper
• Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck.

  2012cited by this paper
• Squamous cell carcinoma of the oral cavity rarely harbours oncogenic human papillomavirus.

  2011cited by this paper
• Point-of-care outcome assessment in the cancer clinic: audit of data quality.

  2010cited by this paper
• Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial.

  2008cited by this paper
• Analysis of risk factors for distant metastases in squamous cell carcinoma of the oral cavity

  2007cited by this paper
• Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)

  2005cited by this paper
• Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.

  2004cited by this paper
• Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

  2004cited by this paper

• Statistical Analysis of Clinicopathological Factors Influencing Distant Metastasis in Oral Squamous Cell Carcinoma

  2025cites this paper
• Progressive loss of upper limb function as a presenting feature of glenohumoral metastasis from a primary tongue malignancy

  2024cites this paper
• Prediction of Histological Grade of Oral Squamous Cell Carcinoma Using Machine Learning Models Applied to 18F-FDG-PET Radiomics

  2024cites this paper
• Current Treatment Strategies and Risk Stratification for Oral Carcinoma.

  2023cites this paper
• Individualized Risk Assessment of Distant Metastases in Oral Cavity Carcinoma: A Validated Predictive-Score Model.

  2023cites this paper
• Prediction Model of Distant Metastasis in Oral Cavity Squamous Cell Carcinoma With or Without Regional Lymphatic Metastasis

  2022cites this paper
• The copy number variation of GSTM1 as a promising prognostic factor of oral squamous cell carcinoma.

  2022cites this paper
• Comparative prognostic value of different preoperative complete blood count cell ratios in patients with oral cavity cancer treated with surgery and postoperative radiotherapy

  2021cites this paper
• The Potential Impact and Usability of the Eighth Edition TNM Staging Classification in Oral Cavity Cancer.

  2021cites this paper
• [The clinical application of free skin flap transplantation in the one-stage repair and reconstruction after total glossectomy].

  2020cites this paper